To further evaluate the association of SKP2 overexpression with aggressiveness of prostate cancer, we have performed cell migration and invasion experiments, as well as quantitative PCR analysis of the expression of EMT and interferon pathways related genes using a prostate cancer cell line PC3 with or without SKP2 overexpression. The gene discussed is SKP2; the disease is prostate carcinoma.